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1. Introduction 
The development of civilization and extreme technical progress leads to increasing hope of 
longer survival and makes the average life expectancy longer. Both in absolute and relative 
numbers the amount of the elderly, very old and long-aged people are increasing 
(Blackburn & Dulmus, 2007; Ratnaike, 2002). This tendency will continue and it will be 
emphasized by ageing volumes of people born after the World War 2 in the years 2010 -2015 
(Kalvach et al., 2004). The basic survey and knowledge of geriatric medicine will be 
necessary in the future, especially for professionals such as doctors, nurses, psychologists, 
social workers, physio- and occupational therapists etc. 
Knowledge of at least basic extraordinarities and specifics of geriatric medicine will be of 
huge practical significance, because in the year 2050 there will live 2 billions of people older 
than 60 years on the Earth. (Moody, 2009). From this fact it is obvious, that there is an 
objective need to master the basic knowledge of gerontology and geriatry among 
professionals (including doctors of all medical branches). 
In this brief chapter it is not possible to include the whole issue dealing with the medical 
care of old-aged patients with PE, even if this issue deserves the attention because of its 
practical meaning and close relationship with other branches (internal medicine, surgery 
etc.). The emergency situations together with polymorbidity and exhaustion of functional 
reserves in advanced age (Campbell et al., 2008; Friedman et al., 2008) will be more frequent 
in all of the organ systems – cardiovascular, respiratory, GI (gastrointestinal) tract, 
endocrine, immune etc. (Bongard & Sue, 2003; Roberts & Hedges, 2009). We refer to the 
study of the clinical picture description (incl.therapy) of each of critical states in the old age 
in appropriate specialized chapters in this monograph and in other gerontologic literature 
(Hall et al., 2005; Stone & Humphries, 2004). 
General knowledge of these aspects can substantially influence an approach of intensivists 
who face an increasing number of old patients in their practice (Brunner-Ziegler et al., 2008; 
Pathy et al., 2006). Among the aspects we would like to mention there are: global situation, 
specific problem of geriatric medicine, pharmacotherapy in the elderly, at last but not least 
problems of ageing organism as reflected in particularities and pitfalls of medical treatment 
in multi-morbid  old patients.  
Ageing and its manifestation as currently understood such as frailty, functional disorders 
and decreasing mental abilities are not standard symptoms of ageing process but they are 
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mostly consequences of simultaneously on-going diseases (Goldmann et al., 2000; Fauci et 
al., 2008). The target of new interventional gerontology is extension of active life period and 
sustaining functional abilities for maximum time. 
Information about function can be used in a number of ways: as baseline information, as a 
measure of the patient's need for support services or placement, (Tallis & Fillit, 2003) as an 
indicator of possible caregiver stress, (Asplund et al., 2000) as a potential marker of specific 
disease activity, to determine the need for therapeutic interventions, and to indicate prognosis. 
2. Comprehensive geriatric assessment (CGA) as basic tool of modern 
geriatry  
Clinical gerontology emphasises an individual approach to old patients (Harari et al., 2007; 
Soriano et al., 2007). The method of operation is comprehensive geriatric assessment - CGA 
(Gupta, 2008; Gurcharan & Mulley, 2007; Williams, 2008). Apart from somatic aspects of the 
health status there are significant items to be underlined: self-sufficiency evaluation, 
knowledge and evaluation of psychic state and social conditions (see tab. 1). 
Much of what has been written on evaluation of the older patient is simply attention to the 
details of careful clinical assessment. Contemporary emphasis on efficiency and 
effectiveness of clinical care requires thoughtfulness about any extension of the already 
lengthy evaluation of complex chronic medical problems that commonly cluster in older 
persons. Brief screening questions rather than elaborate instruments are appropriate for the 
first encounters (Stuck, 1995); more detailed assessment should be reserved for patients with 
demonstrated deficits (Applegate et al., 1990).  
 
Subject of assessment Way of evaluation 
Somatic status 
Somatic examination, posture, mobility, continence, 
nutrition, sight, hearing, geriatric syndromes, etc. 
Self-sufficiency ADL- test, ability to keep own household, IADL- test 
Mental status 
cognitive function – MMSE- test, Clock test; depression 
scale according Yesavage, etc. 
Social status 
social contacts, people available to summon  help, 
bereavement, removal, dwelling and loneliness risks 
Table 1. Comprehensive geriatric assessment 
In its multidisciplinary context the geriatry does not substitute other clinical medical 
branches in care of an old person but completes them with application of specific geriatric 
regimen, which aims to reinforce the independence and improve self-sufficiency of the 
older patients (Williams, 2008). Following methods are based on principles of specific 
geriatric regimen. 
 Considerate tailor-made diagnostics and treatment aimed at improvement of life 
quality 
 Follow up physiotherapy 
 Multi-disciplinary team active approach aimed at improvement of self-sufficiency 
and/or prevention of dependence 
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 Social work creating conditions enabling patients to return to home environment (incl. 
home-care) 
Main target of these efforts is improvement in independence and self-sufficiency 
improvement in older patients (Zavazalova et al., 2007). Geriatric regimen brings benefits 
especially for patients aged 75+ or even 80+ who are endangered with following risks 
typical for this age: 
- Development of immobilisation syndrome 
- Self-sufficiency loss 
- Atypical pathway of more diseases influencing simultaneously each other 
- Occurrence of early impairment of organ function as a consequence of exhaustion of 
their functional reserve (lungs, kidneys etc.) 
- Maladaptation towards changes 
- Ageism (discrimination because of the old age). 
Evaluation of the older patient can be time-consuming (Topinkova, 2005), even when it is 
tailored to the problem. Yet, such initial investment can reduce subsequent morbidity and 
resource utilization and enhance both patient’s and physician’s satisfaction. Additionally, 
the assessment can often be accomplished over several visits. Moreover, much can be 
gleaned from questionnaires filled out by the patient or caregiver in advance as well as from 
observation. 
3. Geriatric patient – particularities of health status  
Geriatric patients are people of higher age (formally above 65; practically above 75 years), 
their involutionary and morbid changes (usually multi-morbidity) significantly influenced 
their functional state, adaptability, ability of regulation, toleration to stress. These patients 
profit from specific geriatric attitude, they need more complicated coordination of services, 
often active observation of health and/or functional state, they are in risk of sudden loss of 
self-sufficiency, danger of delay, adverse effect of remedies is more frequent, institutional 
care is often needed ( geriatric hospitalism), also they are in danger of frequent professional 
mistakes for atypical symptoms in comparison to clinical picture, which is for certain 
disease typical in adult middle age (Friedman et al., 2006; Pathy et al., 2006; Williams, 2008). 
The following principles of geriatric medicine are helpful to keep in mind while caring for 
older adults:  
1. Diseases often present atypically.  
2. Many disorders are multifactorial in origin.  
3. Not all abnormalities require evaluation and treatment.  
4. Polypharmacy and adverse drug events are common problems.  
Comorbidities are common in older people, and the diagnostic "law of parsimony" often 
does not apply. A disorder in one organ system may lead to symptoms in another, 
especially the one that is compromised by preexisting disease. Since these organ systems are 
often the brain, the lower urinary tract, and the cardiovascular or musculoskeletal systems, a 
limited number of presenting symptoms – i.e., confusion, falling, incontinence, dizziness, 
and functional decline - predominate irrespectively of the underlying disease. Thus, 
regardless of the presenting symptoms in older people, the differential diagnosis is often 
similar.  
Many abnormal findings in younger patients are relatively common in older people and 
may not be responsible for a particular symptom. Such findings may include asymptomatic 
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bacteriuria, premature ventricular contractions, and slowed reaction time. In addition, many 
older patients with multiple comorbidities may have laboratory abnormalities that, while 
pathologic, may not be clinically important. A complete workup for a mild anemia of 
chronic disease in a person with multiple other issues might be burdensome to the patient 
with little chance of impacting quality of life or longevity. 
Ageing is associated with a decline in expectation of healthiness. Those over age 65 
generally give more positive evaluations of their healthiness in the face of increasing burden 
of disease and disability (Kriegsman et al.., 1996; Tinetti et al., 2000). The older the person is, 
the more likely they are to report very good health status (Gross et al.., 1996). However, 
overestimating healthiness (also called normalization) often results in explaining away 
symptoms or problems as caused by minor illnesses or even by external events. In either 
case, late recognition and delayed intervention are the usual outcome. Previous neglecting 
of symptoms by health care professionals is also likely to teach older patients that frailty and 
loss of independence are normal and to be expected with ageing; again, late detection and 
intervention are likely, resulting in high cost and discouraging outcomes. Perhaps these 
attitudes explain the finding of greater pessimism in older persons compared with those 
middle-aged, even when health status was factored in. Underreporting of symptoms is a 
common theme in discussions of illness behavior of older persons. 
The problems identified were common and usually treatable diseases; congestive heart 
failure, correctable hearing and vision deficits, tuberculosis, incontinence, anemia, 
bronchitis, claudication, cancers, malnutrition, diabetes, immobility, oral disease preventing 
eating, dementia, and depression were frequent. Considerable underreporting was also seen 
among people with chronic diseases. More than a half of chronically ill individuals, who 
were surveyed in one study, failed to report at least one disease. Older people tend to report 
inaccurately cardiac disease, arthritis, and stroke (Kriegsman et al.., 1996). 
The riskiness of underreporting of symptoms by older patients is obvious; late identification 
of disease (inclusive of PE) leads to late initiation of treatment, usually after substantial 
morbidity associated with advanced pathology has already occurred and caused major 
functional losses. Rehabilitation to independence from these losses is difficult; permanent 
dependence in spite of "successful" treatment may occur.  
Majority of all biological functions culminates before the age of 30 y. Some of them 
gradually continuously decrease afterwards (Masoro & Austad, 2006). This decay is 
practically of no significance in terms of current everyday activity but it can matter under 
stress or extended load (Humes, 2000; Hunter et al.., 2002). 
Seniors as such represent very heterogenous group and from the point of wiev of fitness, 
risk and need of help (or specific service) they can be divided to the 3 basic areas with 
different focus of health attention: 
 Fit seniors – Seniors in good condition and physical efficiency. Medical attitude 
towards them should be the same as standards which are valid for adults in middle age. 
However, there can be also risk of atypical symptoms of diseases in them. 
 Independent seniors – do not need extraordinary care and services, they can live 
independently in standard condition, however in stress situations (severe diseases, 
surgery, injuries, viral infections in epidemies, extreme variation of the weather, sudden 
change of social state – death of partner, loneliness, moving etc.) they fail. 
 Frail seniors – are instable and in the risk even in standard condition. These frail 
seniors usually need help in common daily activities or they are limited in motion, 
moreover they are confined to bed (Fried et al.., 2005; Wawruch et al.., 2006). This group 
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of patients contains those with higher risk of falls, dementia syndrome, with very bad 
mobility, labile somatic disease (i.e. frail cardiac with repeated cardiac failure or electric 
instability), also with complicated orientation (visual disturbance and hearing loss), 
people in social distress and very old above 85 years old, especially when they live 
alone (Leng et al.., 2007; Yaffe et al.., 2007). 
Health status in ageing is a result of many factors, including the chronic diseases of ageing 
and many other prevalent conditions that cannot be defined as classic "diseases" because 
they do not result from a single pathologic cause. Falls, which occur in one third of older 
adults, result in injuries, fractures, and high risk for disability and mortality. Severe 
cognitive impairment and urinary incontinence have a substantial adverse impact on an 
elderly person, as does sensory isolation resultnig from hearing and visual impairment; all 
of these conditions are frequent with aging. 
Older patients differ from young or middle-aged adults with the same disease in many 
ways, one of which is the frequent occurrence of comorbidities and of subclinical disease.  
A second way in which older adults differ from younger adults is the greater likelihood that 
their diseases present with nonspecific symptoms and signs. As a result, the diagnostic 
evaluation of geriatric patients must consider a wider spectrum of diseases than generally 
would be considered in middle-aged adults. 
4. Biology of ageing  
Ageing and advanced age is a terminal phase of ontogenetic development of every 
individual (Beers et al., 2006; Pathy et al., 2006). Specific degenerative morphological and 
functional changes occur in individual organs at all levels from the cells to whole organism 
(Heltweg, 2006).  Important role in aging is apoptosis. In the cell, which may compromise 
the body (eg, activated leukocyt, as malignant cells), respectively a correction would be 
difficult to run programmed cell death.   
Despite the biologic controversy, from a physiologic standpoint human ageing is 
characterized by progressive constriction of the homeostatic reserve of every organ system. 
This decline, often referred to as homeostenosis, is obvious by the third decade and is gradual 
and progressive, although the rate and extent of decline vary. The decline of each organ 
system appears to occur independently of changes in other organ systems and is influenced 
by diet, environment, and personal habits as well as by genetic factors.  
Even beyond age 85, only 30% of people are impaired in any activity required for daily 
living and only 20% reside in a nursing home. Yet, as individuals age they are more likely to 
suffer from disease, disability, and the side effects of drugs, all of which, when combined 
with the decrease in physiologic reserve, make the older person more vulnerable to 
environmental, pathologic, and pharmacologic challenges.  
This happens in different periods of times and in different speed. It affects any living 
substance from the moment of it’s birth (conception). The life expectancy of an individual in 
nature is species specific and has important inter-individual variability. Ageing speed of an 
individual is genetically coded – it is presumed that this type of genetics is a multi-factorial 
one (Masoro & Austad, 2006). Maximum potential life expectancy of a human being 
attainable under ideal circumstances could be 110 - 120 y. The influence of genetic factor on 
the life expectancy is considered about 35 per cent. The resting 65 per cent represent an 
influence of a life style and external environment.    
Common and typical features of ageing in general:   
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1. loss of functional parenchyma of individual organs = involution 
2. decay of physical performance, deteriorated regeneration after load and reduced 
tolerance towards load 
3. influence of one or more diseases 
4. disintegrated ageing: big inter- and intra-individual differences (organs and systems) 
5. effort to create new own homeostatic mechanisms (which accompanies growing 
involution) = adaptability.  
Senile performance decline is a consequence (Beers et al.., 2006) of general weakness, 
impaired locomotion and balance, lower stamina. The life expectancy is significantly 
influenced by risk factors, contingent metabolic changes and level of resistance to stress. A 
choice of life style is also essential. Ageing in human population is often connected with 
increased occurrence of degenerative affections, tumours and Alzheimer’s disease 
(Holmerova et al., 2007).  
In fact it should be a period of life in which broad harmonic development of human 
personality goes on and on. Most people of advanced age should remain independent, self-
sufficient and retaining their good psychic condition up to the terminal period of their life 
(Nemeth et al., 2007). 
5. Epidemiology and demography of ageing  
In the beginning of the 20th century 3 to 5 per cent of population in European industrial 
countries (similarly in USA) were people aged 65+ y. This percentage has grown up to 14 – 
20 nowadays. Up to the fifties of previous century people died prematurely. During the last 
hundred years the life expectancy (LE) almost doubled which is one of the greatest 
achievements of mankind and science in general. Length of human life begins to approach 
to its biological limit. Probability of achieving advanced age is no longer exceptional, on the 
contrary it becomes a standard (Fauci et al., 2008; Pathy et al., 2006; Ratnaike, 2002).  
Demographically, the ageing population due to changes in mortality and fertility decline – 
fewer children are born and more people live to old age. Crucial in this is played by more 
improved standard of living than in the past and progress of medicine. 
Absolute and relative growth of number of the elderly both in developed and developing 
countries is a main feature of population development in the 21st century (Scherl, 2003). We 
speak about population ageing. There are approx. 580 mil. people aged 60+ in the today’s 
world out of which 355 mil. live in developing countries. In 2050 there will be 2 billions of 
our planet inhabitants aged 60+ y. This age category will overweight children of < 14 y. The 
most rapid increase during the next decades is envisaged in the 80+ y. group in the 
industrial countries. It is the ageing of old population (Buttler, 2003). In the USA (fig.1), 
Canada and majority of European union countries it has been found that the most rapidly 
increasing group of population is the one of 85+ y. 
Ageing in the industrial (developed) countries can be considered: 
 prevailingly gradual 
 connected with birth rate decrease 
 a consequence of improving life conditions after the industrial revolution 
 progress in medicine 
In the developing countries on the other hand: 
 ageing is more rapid 
 birth rate decrease is dramatic 
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 life expectancy grows as a consequence of improving medical care 
 ageing leads to enhanced poverty 
In 2020 aged 60+ - 70 per cent of them will live in the developing countries. The highest 
proportion of these elderly is envisaged in Japan (31 per cent), than in Greece and 
Switzerland (28 per cent), USA (23 per cent), etc. 
 
 
Fig. 1. Demographic prognosis of old age population in the USA   
The growth of population aged 65+ in Europe and Northern America during the next 30 
years is estimated to reach 24 – 35 per cent. Growing number of the elderly brings also both 
absolute and relative increase of occurrence of affections which are typical for the advanced 
age and this becomes a serious worldwide social problem (Seitz, 2003). This covers not only 
typically somatic diseases such as atherosclerosis, cardio- and cerebrovascular events, heart 
failure, peripheral vasculopathies, parkinsonism, hypo-thyreoses, diabetes, osteoporosis and 
osteoarthrosis, diverticulosis, anemies,  etc. but also mental diseases with all manifestations 
and consequences of dementia, especially the Alzheimer’s type (Braunwald et al.., 2001; 
Sinclair & Finucane, 2003). 
Analogically to the population ageing in society also medical science has experienced a 
phenomenon of the so called “geriatrisation of medicine” which means a significant 
prevalence of the elderly among all the patients to be treated (Asplund et al.., 2000). This 
aspect penetrates practically all the branches of medicine to begin with the front line up to 
the various special fields including ophtalmology.   
6. Characteristics of ageing  
The elderly are highly heterogeneous group, and individuals become more dissimilar as 
they age. Individuals over 65 years – with or without chronic diseases – vary widely in their 
physical, behavioral, and cognitive functions. 
The ageing – is an inevitable physiological process, which is the last ontogenetic period of the human 
life. People mostly achieve their old age without any enormous problems. They live to their 
„successful ageing“. in quite comfortable physical, psychical and social balance (Duthie et 
al., 2007; Williams, 2008). The somatic (diseases), psychical (dementia, depression) and social 
(loneliness) problems begin to appear apparently after 75th year ( more in women) (Barba et 
al.., 2000) 
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The old age and the disease cannot be considered the same thing no matter how often it happens in 
both non-professional and professional community. In most cases the individual in old age 
is self-sufficient and fit until the last period of his/her life (many times until the last days). 
The dependence on care of the others comes with the disease, which can be both somatic 
and psychical. In between 65 and 75 years nearly 85% of people do not suffer from any 
significant modifying or common life restricting disease. Even in the age above 85 years 40% 
of the elderly can live self-sufficiently their normal life (Gammack & Morley, 2006). 
Women live usually 7 – 8 years longer than men (Tallis & Fillit, 2003). The explanation can 
be found most likely in gender specific genetic factors and also in biological factors of the 
environment. The differences in surviving between genders has not changed even in 
contemporary era, when women smoke more often than ever before and perform originally 
male professions. 
In gerontology we speak sometimes about the so-called male overmortality. The 
consequence of this phenomenon is increasing number of widows as the age increases. This 
is the base for the typical phenomenon in gerontology – the phenomenon of lonely old 
women. That fact indirectly increases the consumption of both institutional and non-
institutional care in the health and social sphere. 
The beginning of the social old age is usually seen in the moment of entitlement to regular 
retirement or the actual retirement (Blackburn & Dulmus, 2007; Woodford & George, 2007). 
The classification of the human age in social sphere is as follows: the first age (before 
productive age, childhood and youth, learning, preparation for profession, acquisition of 
social experience), the second age (productive age, adulthood, biological productivity – 
breeding, economical and social productivity), the third age (postproductive, the old age), 
eventually the fourth age (the period of dependance), which does not take place in every 
person inevitably. The calendar age is uniquely determined but does not reflect the 
individual differences of the real health status among the human beings. 
The determination of the age zones for the old age is conventional and it is a social frame 
outgoing from the administrative needs of the social state. In the demographic statistics it is 
usually worked with the border of 60 or 65 years. Nowadays the beginnig of the old age is 
thought 65 years and the old age itself is considered from 75 years on. From this pattern also 
the most used division of the old age results: 
- 65 – 74 years old belong to group of young seniors, the main problem is the retirement, 
the free time, activities, self-fulfillment. 
- 75 – 84 years, the old seniors, the problem of adaptability, toleration to stress, specific 
ailment, loneliness. The age above 75 years, when the old age begins in the strict sense 
of the word, it seems to be breaking point of ontogenesis, when more significant 
changes connected with physiological ageing proceed. 
- 85 and more years  very old aged seniors („oldest old“) – they are segregated as an 
individual cathegory for the high occurrence of frail seniors and high risk of sudden 
rise of dependency. 
7. Geriatic syndromes and frailty as golden grale of geriatric medicine   
Presentation of illness in older persons less often is a single, specific symptom or sign, which 
in younger patients, announces the organ with pathology. Older persons often present with 
nonspecific problems that are in fact functional deficits (Kalvach et al., 2008). Stopping 
eating and drinking, or the new onset of falls, confusion, lethargy, dizziness, or incontinence 
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in older patients may be the primary or sole manifestation of diseases with classic signs and 
symptoms in the young (e.g., pneumonia, myocardial infarction, pulmonary embolus, 
alcoholism or myxedema). These deficits have been named geriatric syndromes; they 
devastate independence without producing obvious or typical indications of disease. 
Geriatric syndromes may be defined as a set of lost specific functional capacities potentially 
caused by a multiplicity of pathologies in multiple organ systems. Comprehensive 
evaluation (Tinetti et al.., 2000) is usually required to identify and treat underlying causes. 
Although in many instances a geriatric syndrome has several contributing causes, 
remedying even one or a few may result in major functional improvement.  
The most likely explanation for nonspecific presentation is that the additive effects of ageing 
restrict capacity to maintain homeostasis. Perturbation of homeostasis by disease, trauma, or 
drug toxicity will be manifested in the most vulnerable organ, or the weakest link, resulting 
from interactions of biologic ageing and chronic disease. In addition to nonspecific 
presentation, disease in older patients can present in other atypical ways. Blunting or 
absence of typical or classic symptoms and signs is well described in many conditions 
(Doucet et al.., 1994; Perez-Gusman et al.., 1999; Trivalle et al.., 1996).  
Health status in ageing is a result of many factors, including the chronic diseases of ageing 
and many other prevalent conditions that cannot be defined as classic „diseases“ because 
they do not result from a single pathologic cause. Many of the problems affecting aged 
individuals should be viewed as geriatric syndromes (GS), that are a collection of signs and 
symptoms with a number of potential causes (Hazzard, 2007). Only nowadays the causes 
and effective treatments of these conditions are beginning to be understood.  
In spite of indisputable significance of the atypical clinical picture of diseases in the old age, 
the crux of geriatric medicine is involutionarity conditioned decline of health potential, frailty 
and related geriatric syndromes and function deficiency with their multicausal reasons. This 
status is connected with exhaustion of organ reservoirs – “homeostenosis”. Geriatric 
syndrome is different from the convenient meaning of the word “syndrome” in clinical 
medicine, where the symptoms are typical for certain disease (Inouye et al.., 2007; Pathy et 
al., 2006). For the geriatric syndromes numerous and various causes are typical which lead 
to the occurence of geriatric syndrome at the end.  Geriatric syndromology is an essential 
component of the so-called comprehensive geriatric assessment (CGA) which is extended 
over the clinical examination in younger non-geriatric population (Gupta, 2008; (Gurcharan 
& Mulley, 2007; Williams, 2008). 
Geriatric giants (Chase et al.. , 2000; Sherman, 2003;) as geriatric syndromes (GS):  
 immobility (pressure sore etc.),  
 instability (dizziness, posture and gait disorders, falls),  
 incontinence,  
 intellectual disorders (delirium, dementia and depression), 
 iatrogenia (dangerous polypharmacy).  
They are characterized by their:  
a. Multicausality 
b. Chronic course 
c. Reduced independence 
d. Demanding care and difficult curability 
As further geriatric syndromes are respected (44,49): 
 syndrom of hypomobility, decondition and sarcopenia 
 anorexia syndrom and malnutrition 
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 syndrom of dual combined sensoric deficiency (visual and hearing) 
 syndrom of dehydration with subsequent manifestation of acute renal failure 
 syndrom of thermoregulatory disturbance 
 syndrom of elder abuse, neglect and self-neglect sy  
 syndrom of geriatric maladaptation  
 syndrom of terminal geriatric deterioration - FTT („failure to thrive“) 
The above mentioned geriatric syndromes not always threaten patient’s life but they 
essentially influence quality of their following life (Fauci et al., 2008; Salvedt et al.., 2002). 
Patients become fully dependent on other people´s assistance (family, friends, neighbours, 
community services). Not exceptionally they must be admitted to an institutional care 
(hospitals, nursing homes etc.) because of domestic care system failure or necessity to 
manage an acute phase of a disease.  The expression of the concept of geriatric syndromes in 
the last decades is a very fundamental step forward in geriatric medicine. The marked part 
of multi-morbid disabled handicapped seniors can be better understood and earlier and 
effectively solved (Williams, 2008). GS are more complicated problem with inner 
connections very often. Their proper identification is made possible by: 
 screeenig tests and observation 
 optimalisation of geriatric hospital regime 
 optimal coordination of community and institutional services 
 influence on anorexia by adjustment of nutrition ( proteins 1.3g/kg) 
 psychotherapeutical support with elimination of the depression 
 lasting physiotherapy ( everyday walking at least for 30minutes) 
 attempting to influence the disinterest and weariness by interesting daily activity 
 using all of the occupational utilities, which can minimise the dependence ( walker, 
rods, crutches, wheelchairs and other – glasses, magnifying glass, hearing aids 
 recondition programs 
 adjustment of the living ( lightning, grab handles on toilet and corridors, the correct 
hight of the bed and furniture) 
The involutionary loss of muscle tissue in the old age is called sarcopenia and it is 
characterized by reduction of muscle tissue, reduction of the force, tenacity, plasticity and 
speed of contraction (Roubenoff & Hughes, 2000a). The probable cause of sarcopenia in 
senium (Roubenoff, 2000b) is apart from somatopausis (lowered level of anabolic IGF-1, 
growth hormone and testosterone) also influence of oxidatory stress and free radicals  
produced by muscle mitochondrias (Masoro & Austad, 2006). The metabolic result of 
sarcopenia in the old age is also impaired glucose tolerance and higher risk of diabetes of 2nd 
type (Fauci et al., 2008; Sinclair & Finucane, 2001). 
The meaningful concept which is tightly connected with ageing is frailty (Friedman et al., 
2008; Rockwood & Hubbard, 2004; Woodhouse & O'Mahony, 1997). This belongs to key 
characteristics of geriatric patients, the next milestone and the keystone of geriatric medicine. 
Frailty is a biologic syndrome (Crome & Lally, 2011) of decreased reserves in multiple systems 
that results from dysregulation that can occur with ageing and is initiated by physiological 
changes of ageing, disease, and/or lack of activity or inadequate nutritional intake.       
It is rather more multidimensional concept than just the expression of a degree of dependence 
in the everyday life activities. Frailty is basically connected with the grow of fatal somatic 
ailments and lowering of functional reserve of the old person, which is wasting away 
excessively without any fundamental cause disease (Juraskova et al., 2010). Frailty can be 
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defined as a status of reduced physiological reserves connected with increased inclination 
towards invalidisation (falls, fractures, daily life restrictions, loss of independence – Leng, 
2007; Walston, 2006). Apart from the clinical observations there is elevation of CRP, leukocytes 
(monocytes), IL-6, IL-1 and TNF. Frailty is not the synonym of multi-morbidity or disability, 
multi-morbidity can cause this and disability can be the consequence (Fried et al., 2005). 
Frailty is understood mainly as a risk of sudden deterioration of the status of very risky person. 
(above 80 years, living alone or with handicapped spouse, with serious somatic or psychical disease).  
The outcome for those defined frail seniors is the long term need of help of institutions and 
community (nursing service). The risks of the development of frailty (Friedman et al., 2006; 
Szanton et al., 2010) are represented by hypomobility in pre-senium, social isolation, 
depression, bad subjective feeling of the own health etc.  
The concept of frailty is at least coming nearer to the term risky geront, used in the past. The 
emphasis is put on the retrieval of these people because they can not show their frailty out. 
Both (the ageing and physical frailty) are conditioned by the decline of proteosynthesis in 
the muscles, decline of immune function, elevation of the mass of fat in the body and 
lowering of the amount of body water, lowering of the bone mineral density, loss of the 
whole body mass and strength.  
The main etiological and patogenetic mechanisms (Leng et al., 2007; Walston et al., 2006) of 
the syndrome of frailty are: 
 the inflammation or hypercoagulation 
 oxidative stress 
 insulin resistence 
 anorexia with loosing of the weight and malnutrition 
 sarcopenia 
 fall of efficiency of lower hints 
 loosing of spontaneous action – nutrition, hydration, movement, behavioral and social 
 dysfunction of autonomic nervous system ( falls, sarcopenia, decubital ulcer and 
healing – with the consequence like loosing the weight, incontinence, delirium, 
disturbance in thermoregulation etc.) 
 apathy – as the consequence of lack of the dopamine in CNS ( depression, dementia) 
 depression, anxious status, organic psychosyndrome 
 development of cognitive deficiency 
 menopausis and andropausis as the consequence of hormone deficiency with the 
development of the syndrome ADAM and PADAM, somatopausis as the result of lack 
of IGF-1 
 chronical pain 
 hypomobility with the sedentary lifestyle 
 chronic stress 
 functionally important consequences of chronic diseases which limit in an activity 
(hemiparesis, severe diabetic neuropathy, respiratory or heart insufficiency, hard 
anemia of chronic diseases) 
 adverse effects of the medicaments 
8. Polypharmacy in the elderly  
Polypharmacy is a common problem in the elderly. Particularly in those who have multiple 
comorbidities. Their therapy should be guided by the estimated life expectancy and  
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the patients' values and goals. Interventions that are likely to help the elderly, who are  
well, may differ from those that will benefit the ones who are frail. Estimating life 
expectancy can help a health care provider to focus on those issues to be most likely 
beneficial in the given patient. 
There are several reasons for the greater incidence of iatrogenic drug reactions in the elderly 
population, the most important of which is the high number of medications that are taken 
by the elderly, especially those with multiple comorbidities (Blackburn & Dulmus, 2007; 
Duthie et al., 2007). Older individuals often have varying responses to a given serum drug 
level. Thus, they are more sensitive to some drugs (eg. opioids) and less sensitive to others 
(eg. beta-blockers).   
Following aspects should be considered in the old-age pharmacotherapy (Katzung, 2003): 
1. Responses to drugs are different from preceeding age categories which is a consequence 
of changed  pharmaco-dynamics and pharmaco-kinetics.  
2. Increased occurrence of undesired effects of drugs in general  
3. Increased non-compliance in the elderly 
4. Increased occurrence of drug interactions 
Multi-morbidity of advanced age often leads a physician in clinical practice to 
polypharmacotherapy (Nikolaus, 2000; Soriano et al., 2007), which is many times inevitable 
but still is sometimes hazardous because with increasing age an occurrence of undesired 
drug effects grows. The elderly are generally more vulnerable and the therapeutic range 
gets narrower. Compliance decreases inter-individual variability of an effect increases the 
same way as the risk of drug interactions. Basic requirement for phamacotherapy in 
advanced age is that it should be simple, purposeful and effective. Polypharmacy can be 
often risky and ineffective, many times it can be even damaging – iatrogenia as a syndrome. 
In geriatric medicine generally symptomatic treatment overweights the causal one. Its 
undesired effects can substantially alter the clinical picture of diseases.    
The consumption of drugs in the elderly treated within the institutional care is three times 
higher when compared to the same number of individuals from general population and 
female patients need twice as many drugs as the male ones.  
Distribution of drugs depends on the body composition as mentioned, bonds to plasmatic 
proteins and blood flow trough tissues. Poorly nourished or frail elderly persons may have a 
low serum albumin. A cardiac output in advanced age decreases, peripheral vessel 
resistance grows, liver gets smaller and blood flow trough liver and kidneys decreases. 
Bigger part of the cardiac output in comparison to the younger ones flows through the 
brains, heart and skeleton muscles. This also plays a role in the drug distribution.  
9. Problems and complications of polypharmacy 
Occurrence of undesired drug effects is generally 3 – 5 times higher in advanced age when 
compared to preceding age categories (Beers et al. , 2006). Higher consumption of drugs 
brings along higher risks (including deep venose thrombosis - DVT and PE). Side effects 
occur in 2 per cent of the elderly using less than 3 drugs at a time during a year. This 
percentage grows up to 17 in those who use 10 drugs. Combination of more drugs is 
preferred recently more and more frequently to mono-therapy. Except for expected and 
beneficial effect of synergism it can bring also adverse side effects. Number of new drugs 
especially in psychiatry and neurology grows dramatically during last decades. The most 
frequently prescribed drugs today are anxiolytics and antidepressants. They are often 
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required also by the elderly and their usage grows also in internal medicine, geriatrics and 
other non-psychiatric medical branches. One third of the undesired drug effect is 
predictable and mere reduction of a dosage can eliminate two thirds of them.  
These undesired effects are often wrongly diagnosed which leads to prescription and 
administration of further drugs – it is a so called  prescriptive cascade. Correct medication 
(both with prescription drugs and commercially available medicaments) is based on the 
right indication appropriate dosage and forms adapted to intellectual potential and somatic 
skills of a patient, elimination of predictable undesired effects and drug interactions and 
minimisation of their impacts on patient, consideration of optimum period of drug 
administration and consistent monitoring of permanent administration connected with 
continuous evaluation of compliance (Katzung, 2003). Non-compliance occurs in 25 – 50 per 
cent of older patients taking drugs regularly.  
When prescribing a drug the physician should ask:         
 Which drug is the most convenient one regarding multi-morbidity and predictable drug 
interactions? 
 What is the optimum dosage? 
 Is a drug indication definite and undoubtful?  
10. Multimorbidity in old age and its relations 
Multiple pathology, or concurrence of diseases, is common among older persons. An early 
Scottish study of community-dwelling persons over age 65 reported 3.5 major problems per 
person; for those being admitted to hospitals, 6 disorders were documented per patient. 
Multiple pathology (Crome & Lally, 2011) poses multiple risks to older patients and their 
physicians. The first hazard is that active medical problems frequently interact to the 
detriment of the patient -disease-disease interactions.  
Late detection of treatable problems whose neglecting and interaction have led to functional 
decline is common in older patients and can be one of the few discouraging features of 
geriatric care. Preventive dental and medical care could have avoided the sepsis, worsening 
of diabetes, fall, hip fracture, postoperative heart attack, stroke, and loss of independent 
living.  
The interaction between old age and illness causes specific changes of diseases in senium 
(Beers et al., 2006; Pathy et al., 2006; Ratnaike, 2002). 
Particularities of illness in old age include: 
 Multi-morbidity – parallel occurrence of more illnesses in one person with or without 
causality relationship 
 Mutual causality of social and health situation – each of the changes of the health state 
in old age influences their social status and vice versa 
 Among the specialities of clinical picture of illnesses in old age we can list: 
1. microsymptomathology – minimal symptoms of diseases (the iceberg phenomenon) 
2. mono- or oligosyptomatology – sporadic symptoms from those, which occur usually in 
middle or young age 
3. distant signs – to the forefront of clinical picture there are symptoms, which belong to 
the difficulties of other organ than the basic one ( “the innocent organ complains, not 
the sick one”) 
4. tendency to chronicity – even in the diseases which are in younger and middle age 
acute, moreover in old age there is higher risk of death 
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5. tendency to complications -  either of type of “chain reaction” or it is the complication, 
which does not have the direct relation (“crowd-out effect”)  
6. atypical picture of the diseases – „For the diseases in the old age it is typical that their 
running is atypical“ 
The proper symptomathology of the basic disease is usually inconspicuous. In the clinical 
picture manifestation of non-specific and universal symptoms dominates. These are the 
results of the secondary brain decompensation. Among those the universal neurologic and 
psychiatric symptomathology conditioned on hypo-perfusion (hypoxia) of the brain (TIA, 
delirium etc.) belong. The senior's brain is usually affected with the degenerative or vascular 
changes and reacts usually as the first organ. 
Among the causes of the morbidity in old age the forward position (Tallis & Fillit, 2003) is 
being taken by the diseases of the cardiovascular system conditioned with atherosclerosis like 
CHD (coronary heart disease), MI (myocardial infarction), angina pectoris, stroke,  transient 
ischemic attack, ischemic disease of the lower limbs (atherosclerosis - AS is present in 90% of 
the people above 75 years.). In old age we find common: the diseases of the locomotive system, 
sense organs, tumours, accidental injuries, the diseases of the respiratory tract, gastrointestinal 
tract (biliary problems etc.) and urogenital tract (the prostate in men, gynecological in women). 
Diabetes, mental and neurological disorders are common (Beckman et al., 2002; Sinclair & 
Finucane, 2003). Their coincidental and usually independent occurrence is typical for the 
senior’s multi-morbidity. After the age of 60 there is continuous increase mainly of the 
cardiovascular diseases as CHD, stroke, hypertension (Ferrari, 2003; Oskvig, 1999). Similarly 
with the age prevalence of diabetes rises (Sinclair & Finucane, 2003). 
For the quality of the senior‘s life crucial matter is not the presence of the disease itself (or 
more diseases) but the grade of the disability, it means functional disturbance, into which it 
is proceeding. The full self-sufficiency can be untouched even when there are more diseases 
present together. 
The inclination of the seniors to the diseases is higher (Khaw, 1997) and the balance of the 
organ homeostasis is very frail (eg. homeostenosis). Similarly it is the case of “primary“ 
mental disorders (dementia, depression, delirium) or in the geriatric social syndromes 
(neglect sy, elder abuse, geriatric maladaptation sy). The stressor is usually in psychosocial 
sphere and its clinical manifestation appears most often in cardiovascular area (heart failure, 
MI, stroke) or in impaired immunity (pneumonia). 
As it was mentioned, the diseases and the morbid conditions in old age are marked by many 
extraordinarities. The diseases in old age have the tendency to cumulate and potentiate each 
other. In the geriatric medicine multidimensionality is typical. It is needed to comprehend 
the sick person in old age as the bio-psycho-social unit in more holistic way than in younger 
age from the viewpoint of etiopatogenesis of the disease and also in the case of everyday 
clinical practice. 
The quoted problems from the somatic, psychic and social areas which are in the mutual 
interaction are hardly treatable, they are chronic with the progression of the condition and 
they have relatively unfavourable prognosis. They bring a lot of hardly solvable situations 
and problems to the ill and the surroundings. By the „old old“ people ( ≥ 80 years) the 
diseases proceed in the way (Crome & Lally, 2011), which differ from the progress of the 
diseases in middle age and they need the different approach which can improve the health 
condition or at least maintain the self-sufficiency and they accent the comeback home. 
The most of the biological functions achieve the top before the 30th year of the life. Some of 
them slightly decrease afterwards linearly. For the everyday activity this decrease has not 
www.intechopen.com
 
Pulmonary Embolism in the Elderly – Significance and Particularities 
 
51 
any practical importance, but can be relevant in the time of bigger stress or in the load. The 
physiological processes which are decreasing as the age grows are: blood flow through the 
kidneys, the clearance of the creatinin, the maximum heart rate and pulse volume in stress, 
glucose tolerance, vital capacity of the lungs, body weight, cell immunity. On the contrary 
the total lung capacity and the liver function do not change with increasing age, the 
production of the ADH is even growing. 
Many of mentioned declines, which were thought as natural consequence of the ageing, are 
significantly influenced by the life style, behaviour, diet and environment in which the 
senior has been living. The most important physiological change in old age is the 
predisposition to the higher occurrence of severe diseases. The respiratory functions of a 70 
year old healthy man are the 50% of the 30 years old man. The renal function usually goes 
down in 70 years by 50% and more. This decline in physiological reserve capacity does not 
influence the everyday life but it can influence the ability to recover from the severe disease 
(grave infection, life threatening internal diseases, operations, injuries etc.) 
Some of the physiological changes can simulate a disease even if they are just a usual 
component of the ageing. Diabetes mellitus can appear and disappear in the old age. The 
ability of the insulin to stimulate the take up of the glucose declines with the age and is 
usually manifested as postprandial hyperglycaemia  with normal fasting level of insulin and 
glucose. In the stress situations diabetes can be detected in seniors, but it can disappear 
when the situation gets normal. This loss of the physiological reserves contributes to the 
rising prevalence of diabetes with the rising age. 
The age conditioned changes, which make the old age people more vulnerable in their 
everyday life, are usually mild. In the elderly there is an onset of hypo- or hyperthermia 
easier during the exposition to extreme surrounding influences, because there are a lot of 
changes in the coordination of the lead of the thermoregulation also in the neurological area. 
The loss of neurotransmitters in brain stem can cause typical senile walk, as well as it 
predisposes genetically determined individuals for e.g. to the progress of the Parkinson‘s 
disease. Some of the age conditioned changes cause the specific consequences. The 
menopausis is the physiological process connected with normal ageing but it leads to the 
symptoms, which predispose the organism to the loss of the bone mass and atherosclerosis. 
Apart from clinically obvious forms of the diseases in the elderly the sub-clinical form is 
common as well. Among 6 000 individuals above 65 years which were in the Cardiovascular 
Health Study  (Fried et al., 1991) 31% of them had clinically apparent cardiovascular disease, 
another 37% had sub-clinical form of the disease which was found by non-invasive 
methods.  
The half of the people above 65 years have two or more diseases and these can mean an 
added risk of unfavourable consequences like mortality. In some of the seniors the cognitive 
disturbance can imitate symptoms of a severe disease. The therapy of one disease can act in 
an undesirable way on the other place – such as e.g. use of aspirin as the prevention of the 
ictus in the individual with the anamnesis of the gastroduodenal ulcer. The risk leading to 
disability or dependence on the help is getting higher with the number of co-morbidities. 
Certain couplets of the diseases can increase the risk of disability synergistically. The 
arthrosis and the diseases of the heart co-exist in 1/5 of the elderly, even though the risks of 
progress of disability are 3- or 4-times higher with one of them alone, the risk of both 
together is 14-times higher (Cassel et al., 1997). 
At the end the severe and common consequence of the chronic disease in old age is physical 
disability, defined as the presence of difficulties or dependence on the others when  
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doing common everyday activities, from the basic self-service ( the toilet and washing up)  
to the tasks needed for leading the independent life ( shopping, preparing food, paying  
the bills etc.). 
On the onset and the progress of the critical conditions in old age following factors can 
significantly participate: the poor mobility, loneliness, bad eating habits, insufficient 
hydration, mental deterioration, disturbance of the sight and hearing. The mentioned ill 
individuals have, as it is with multi-morbidity in old age common, an atypical picture, or 
they can be without symptoms or the problems are seemingly moved to the other organ 
area. The important role is played also often by rich pharmacotherapy in old age, which can 
itself cause different organ symptoms (also by the mutual interactions). 
The management of the critical ill persons in old age will demand very active approach from 
the all clinical doctors (not only intensivists) and sometimes also usage of more invasive 
procedures in the diagnostics and therapy of PE, which can act unfavourably in some of the 
cases and sometimes also iatrogenically. 
11. Pulmonary embolism in the elderly - general view of a geriatritian 
The entities of deep venous thrombosis (DVT) and pulmonary embolism (PE) present a 
continuum of venous thromboembolic disease (VTE), which is of crucial importance for 
elderly patients, and offer constant diagnostic and therapeutic challenges to physicians 
caring for patients of any age. For multiple reasons, the incidence of both DVT and PE 
increase with age (Hansson et al., 1997). First, there is often a decrease in the leg muscle 
mass, setting the stage for stasis. There are increased thrombotic tendencies in the elderly 
(Price et al., 1997), beginning around the age of 60, which may involve up to 20% of those 
over age 85; these include impaired vascular wall fibrinolysis and hypercoagulable states.   
The diagnosis of venous thrombembolism (VTE) in the elderly is difficult, although the 
presentation is usually quite similar to that seen in younger patient groups (Matějovská-
Kubešová et al., 2009). The most common presenting symptom of PE is some complaint of 
chest discomfort or pain, seen in approximately 35% of patients in most series, usually without 
hemoptysis. Dyspnea and tachypnea occur frequently. Although circulatory collapse occurs in 
a relatively small proportion of the elderly, these latter patients are much more likely to have 
sustained massive pulmonary emboli and often have evidence of neurologic deficits and 
findings of pulmonary hypertension. Although virtually all younger patients present with one 
of these syndromes, about 10% of the elderly do not, and in the setting of respiratory distress 
this minority may show only confusion or atypical new radiographic findings. The major 
diagnostic strategy (Wells, 1998) required is one of constant suspicion and concern and a 
consideration that, in any older hospitalized patient who is "failing to thrive," to ask whether 
this could be due to pulmonary embolism, because both the symptoms and standard 
laboratory findings are nonspecific and the diagnosis is too often made postmortem. The 
classic triad of hemoptysis, pleuritic chest pain, and clinically apparent thrombophlebitis is 
infrequently seen, in less than 10% of elderly patients with VTE.  
Half of the people, who have PE, have no symptoms. With increasing age the amount of 
people with silent PE is growing. This is, after myocard infarction and cerebrovascular 
events, the third most frequent cardiovascular cause of the death. Simultaneously it is one of 
the least often correctly diagnosed cardiovascular diseases.  
That is a medical emergency because a large embolism, or sometimes many repeated 
smaller ones, can be fatal in a short time. When the heart is continually overworked, it may 
www.intechopen.com
 
Pulmonary Embolism in the Elderly – Significance and Particularities 
 
53 
enlarge, and it may eventually fail to perform. A large PE can cause heart or lung failure. 
This seems to be especially important in advanced age where CHD (heart failure too) has 
growing tendency. Fortunatelly chances of surviving a PE increase when a physician can 
diagnose and treat the patient quickly.  
The acquired and genetic factors contribute to the likelihood of VTE. The acquired 
predispositions include generally long-haul air travel, obesity (Barba et al., 2008), cigarette 
smoking, oral contraceptives, pregnancy, postmenopausal hormone replacement (LaCroix et 
al., 2011; Sare, 2008), surgery (Einstein et al., 2008; Secin et al., 2008), trauma, and medical 
conditions such as antiphospholipid antibody syndrome, cancer, systemic arterial 
hypertension, and chronic obstructive pulmonary disease. Some patients with predisposing 
genetic factors will never develop clinical evidence of clotting (Reynolds et al., 2009). 
PE and DVT are common problems in the elderly (Kniffin et al., 1994). They both increase 
with age, but the effects of race and sex are small. Current treatment patterns appear to be 
effective in preventing both PE after DVT and recurrence of PE. They both are associated 
with substantial 1-year mortality, suggesting the need to understand the role of associated 
conditions as well as the indications for prophylaxis and the methods of treatment. 
Gangireddy (Gangireddy et al., 2007) describes preoperative risk factors associated with 
symptomatic VTE older age, male gender, corticosteroid usage, COPD, recent weight loss, 
disseminated cancer, low albumin, and low haematocrit but not DM. Patients with a low 
probability of PE have a good prognosis in comparison to those having risk factors  
(Bertoletti et al., 2011). In isolation, they have limited diagnostic value and none can be used 
to rule in or rule out PE without further testing (West et al., 2007). 
Necropsy studies in the United Kingdom (Alikhan et al., 2004) and Sweden (Hansson et al., 
1997; Nordstrom et al., 1998) continued to show a high incidence of PE, which was 
considered the main cause of death in about 10% of necropsies. Since the inpatient mortality 
in general hospitals is about 10%, it is estimated that about 1% of patients admitted to 
hospital die from PE. However, for every patient who dies of PE in a surgical ward, three 
die in nonsurgical wards. This is not only a common problem but a serious one: the in-
hospital mortality of elderly patients over the age of 65 with documented pulmonary 
embolism was 21% in the Prospective Investigation of Pulmonary Embolism Diagnosis 
(PIOPED, 1990) Study, and the 1-year mortality was 39% (Stein, 2008).Recent data suggest 
these numbers may be even higher (Heit et al., 1998).  
The clinical non-recognition of venous thrombembolism prior to fatal PE implies that its 
detection and treatment cannot have a major impact on its mortality; hence, identificaton 
and primary prophylaxis of hospitalized in-patients (medical and surgical) at high absolute 
risk of DVT is required for its prevention.  
The high occurrence of PE (particularly its silent form) has crucial importance in the elderly 
mortality. Our recommendations would like to emphasize the need of no underestimation 
of this fact and to carry out preventive measures in all age groups (including “oldest old” 
and frail persons. 
Immobilization in medical ward is due to illness (e.g. infection, malignancy, heart failure, 
myocardial infarction and stroke). The cumulative risk of DVT and PE increases with the 
duration of immobility, suggesting a role for venous stasis in the inactive leg in the 
pathogenesis of DVT.  
Prophylaxis against PE is of paramount importance because venous thromboembolism is 
difficult to detect and poses an excessive medical and economic burden (Kakkar et al., 2010). 
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Mechanical and pharmacologic measures often succeed in preventing this complication. 
Patients who have undergone total hip replacement, total knee replacement, or cancer 
surgery will benefit from extended pharmacologic prophylaxis for a total of 4 to 6 weeks, 
especially with LMWH or UFH about 2 in 3 cases (Bottaro et al., 2008; Reynolds et al., 2009).   
Thromboembolic complications are prevalent in the perioperative period. It has been 
estimated that between 20% and 30% of patients undergoing general surgery develop deep 
venous thrombosis, and the incidence is as high as 40% in hip and knee surgery, 
gynecological cancer operations, open prostatectomies, and major neurosurgical procedures. 
Although fatal pulmonary embolism occurs in 1% to 5% of all surgical patients, it accounts 
for a larger proportion of operative deaths in middle-aged and older individuals. Because 
venous thrombosis and pulmonary emboli can be difficult to diagnose and treat, 
considerable effort has been focused on prophylaxis. 
Patients at high risk can receive a combination of mechanical and pharmacologic modalities. 
Graduated compression stockings and pneumatic compression devices may complement 
mini-dose unfractionated heparin (5000 units subcutaneously twice or preferably three times 
daily), low-molecular-weight heparin, a pentasaccharide or warfarin administration. 
Overall the literature suggests that any association of age with risk of bleeding on heparin or 
warfarin is weak, and contrasts with the strong, consistent finding of an exponential 
increase in thrombembolic risk with age (Kanaan et al., 2007; Kakkar et al., 2010). However, 
geriatritians should consider several practical considerations when prescribing oral 
anticoagulants to the elderly (Beers et al., 2006; Cassel et al., 2003). 
1. Sensitivity to the anticoagulant effect of a given dose increases with age (e.g. decrease of 
daily dose of warfarin) 
2. Polypharmacy (including self-medication) increases the risk of drug interactions which 
alter oral anticoagulant effect, or which increase the risk of bleeding (e.g. aspirin and 
other NSAD) 
3. Increased prevalence of concurrent or intercurrent illness also increases the risk of 
bleeding (e.g. severe anemia, renal failure, gastrointestinal bleeding, hemorrhagic 
stroke, bleeding disorder) 
4. Decreased compliance or decreased access to monitoring – whether performed by the 
general practitioner or hospital anticoagulant clinic – also increases risk of bleeding.  
12. DVT and PE in the elderly – two sides of the same coin VTE 
The continuum of DVT and PE in the elderly is quite similar to that of the younger patient. 
Constant consideration of the diagnosis and application of standard diagnostic and 
therapeutic strategies will be a benefit for the patients and also enhance the mental 
equanimity and professional satisfaction of physicians caring for the elderly. 
12.1 Deep vein thrombosis 
The incidence of deep vein thrombosis increases with age. 
12.1.1 Etiology 
Immobilization, prolonged sitting (as it may occur during long drives or air travel), or even 
a relatively sedentary existence can lead to venous stasis and predisposes to thrombosis, 
because the emptying of veins in the extremities depends entirely on skeletal muscles that 
pump blood and on one-way venous valves that inhibit retrograde flow. Since incompetent 
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venous valves lead to deep vein thrombosis, which damages the valves, deep vein 
thrombosis tends to recur.  
Deep vein thrombosis occurs in 20 to 25% of patients > 40 after routine surgery and in 
almost 50% after hip surgery when no prophylaxis is given. 
12.1.2 Symptoms and signs 
DVT usually occurs in the leg, regardless of the cause. The hallmark symptom is rapid onset 
of unilateral leg swelling with dependent edema – in advanced age predominantly 
asymptomatic. Generally, patients first note swelling when they awaken. In ambulatory 
patients, swelling is maximal at the ankle and lower leg, usually developing over 1 or 2 
days.  
Calf vein thrombosis may produce no symptoms or mild tenderness and mild edema. Calf 
vein thrombosis without swelling is common only among sedentary or bedridden patients. 
Complications of DVT include venous thromboembolism, particularly pulmonary embolism 
(which can lead to death within 30 minutes of onset). 
12.1.3 Diagnosis 
Risk factors (eg, dehydration, estrogen use (LaCrox et al., 2011; Sare et al., 2008), heart 
failure, hip fracture, hypercoagulable states, immobilization or decreased physical activity, 
malignancy, obesity (Barba et al., 2008), polycythemia, thrombocytosis, trauma, venous 
damage) should be sought unless the cause is clear.  
12.1.4 Prophylaxis 
Orthopedic procedures: DVT is common among the elderly because they commonly 
undergo high-risk orthopedic procedures, particularly semi-elective or urgent procedures 
(eg, after a traumatic fracture). If the procedure involves the extremities, the value of low-
dose heparin is limited; full-dose heparin or warfarin is effective, but each has a significant 
risk of bleeding.  
After elective total hip replacement, the incidence of proximal deep vein thrombosis 
(without prophylaxis after surgery) approaches 25%, and the incidence of fatal pulmonary 
embolism is 3 to 4%. Prophylaxis reduces the occurrence of venous thromboembolism by 30 
to 50%.  
Low-dose heparin or low-molecular-weight heparin reduces the occurrence of deep vein 
thrombosis by at least 50%.  
12.1.5 Treatment 
The objective is to prevent pulmonary embolism and chronic venous insufficiency. Patients 
> 70 (especially women) receiving warfarin therapy are at high risk of hemorrhage. Since 
many elderly persons with arthritic or neurologic disorders fall frequently, warfarin is often 
contraindicated in patients > 80 and frail patients > 70. 
12.2 Pulmonary embolism 
Since the symptoms and signs are nonspecific, pulmonary embolism may be overdiagnosed 
or underdiagnosed, especially in the elderly. Patients with cardiac and respiratory disorders 
are especially at risk of misdiagnosis. 
The first step in making the diagnosis is a careful physical examination to evaluate 
alternative diagnoses, for example, congestive heart failure, coronary artery disease, 
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malignancy, and infections that are all frequent in the elderly and may on occasion be 
confused with pulmonary embolism.  
The most common and serious major error is one of omissions, when the diagnosis simply is 
not considered clinically and is confirmed only at autopsy. Pleural changes and possibly 
some local asymmetric changes in vascularity may be detected if the film is keenly studied; 
however, the most common finding is that of an essentially normal chest roentgenogram in 
a very sick patient.  
12.2.1 Etiology 
Bed rest and inactivity pose the greatest risk for developing of deep vein thrombosis. 
Certain medical conditions common among the elderly (eg, trauma to leg vessels, obesity 
(Barba et al., 2008), heart failure, malignancy, hip fracture, myeloproliferative disorders) 
predispose them to venous thrombosis, as do smoking, estrogen usage (LaCroix et al., 2011; 
Sare et al., 2008), tamoxifen therapy, the presence of a femoral venous catheter, and surgery 
(Barba et al., 2008). Risk factors for venous thrombosis are vessel wall injury, stasis, and 
conditions that increase the tendency of the blood to clot, including rare deficiencies of 
antithrombin III, protein C, and protein S as well as disseminated intravascular coagulation, 
polycythemia vera, or the presence of a lupus anticoagulant or antiphospholipid antibodies. 
Ageing is also associated with increased coagulation and products of fibrinolysis, resulting 
in an overall prethrombotic state. 
About 90% of blood clots that cause pulmonary embolism originate in the legs. The risk that 
a clot will embolize and lodge in the lungs is greater if the clot is in the popliteal or 
iliofemoral vein (about 50%) than if it is confined to the calf veins (< 5%). Less common sites 
of thrombosis that may lead to pulmonary embolism are the right atrium, the right ventricle, 
and the pelvic, renal, hepatic, subclavian, and jugular veins. 
12.2.2 Symptoms and signs 
In elderly patients, the most common symptoms are tachypnea (respiratory rate > 16 
breaths/minute), shortness of breath, chest pain that may be pleuritic, anxiety, leg pain or 
swelling, hemoptysis, and syncope. Patients who have small thromboemboli may be 
asymptomatic or have atypical symptoms. Nonspecific symptoms suggestive of pulmonary 
emboli in the elderly include persistent low-grade fever, change in mental status, or a 
clinical picture that mimics airway infection. 
Patients with pulmonary embolism (West, 2007) usually present with one of the following 
symptom patterns: (1) diagnostically confusing syndromes (confusion, unexplained fever, 
wheezing, resistant heart failure, unexplained arrhythmias); (2) transient shortness of breath 
and tachypnea; (3) pulmonary infarction (pleuritic pain, cough, hemoptysis, pleural 
effusion, pulmonary infiltrate); (4) right-sided heart failure along with shortness of breath 
and tachypnea secondary to pulmonary embolism; or (5) cardiovascular collapse with 
hypotension and syncope. Fewer than 20% of elderly patients have the classic triad of 
dyspnea, chest pain, and hemoptysis. If tachypnea is absent, pulmonary embolism is 
unlikely to occur. 
The most common physical findings are tachypnea, tachycardia, fever, leg edema or 
tenderness, cyanosis, and a pleural friction rub. Although most elderly patients with 
pulmonary embolism have deep vein thrombosis as the initial source of the embolus, only 
33% have clinical signs of leg thrombosis. 
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About 33% of elderly patients with pulmonary embolism have pleural effusions, which are 
usually unilateral. About 67% of these effusions are bloody. Bloody pleural effusions 
generally have a pulmonary infiltrate on chest x-ray that suggests hemorrhagic 
consolidation of the lung parenchyma. The infiltrate usually resolves over several days. 
About 10% of patients with pulmonary emboli, especially those with severe heart failure, 
develop pulmonary infarction.  
Syncope, a systolic blood pressure < 100 mm Hg, or a markedly decreased systolic  
blood pressure in a hypertensive patient suggests the possibility of a massive  
pulmonary embolism or, in a patient with marginal cardiopulmonary function, a significant 
embolus.  
A patient who is hypotensive because of pulmonary embolism has elevated right atrial and 
ventricular pressures (as measured by a pulmonary arterial catheter). Thus, a normal right 
atrial or ventricular pressure in a patient with hypotension argues against pulmonary 
embolism as the cause.  
12.2.3 Diagnosis 
The most important consideration for determining the extent of testing is the  
clinical assessment of pretest probability (Bertoletti et al., 2011). The clinical probability 
(Wells or Geneva score) of pulmonary embolism pretest places patients into low-, moderate-
, or high-probability groups. This grouping is combined with the results of ventilation-
perfusion scans or of spiral chest CT scans to determine whether further testing is  
needed. 
Very useful and easy for diagnosis of PE in daily clinical practice in elderly patients seems to 
be the combination of clinical pretest probability (PTP) and D-dimer result (Pasha et al., 
2010). In VIDAS study the combination of a negative D-dimer result and non-high PTP 
effectively and safely excludes PE in an important proportion of outpatients with suspected 
PE (Carrier et al., 2009). 
12.2.4 Laboratory findings 
A chest x-ray, an ECG, and arterial blood gas values should be obtained. If pulmonary 
embolism is still considered to be likely, the next step is usually to obtain a ventilation-
perfusion lung scan. If the lung scan is likely to be indeterminate (because of underlying 
lung disease), spiral chest CT scans may be useful. Finding deep vein thrombosis with 
ultrasonography indicates the need for anticoagulation and usually eliminates the need for 
further testing for pulmonary emboli. The gold standard for diagnosing pulmonary 
embolism is pulmonary angiography. 
Chest x-rays: Results of chest x-rays may be normal or may show nonspecific abnormalities, 
eg, atelectasis, an elevated hemidiaphragm, pleural effusion, or an infiltrate.  
ECG: ECG findings are usually nonspecific; 33% of patients with pulmonary embolism have 
a normal ECG.  
BNP (brain natriuretic peptid) and echocardiography may be also useful determinants of the 
short-term outcome for patiens with PE (Sanchez et al., 2010). 
d-Dimer: Levels of d-dimer, a fibrin-specific product, are increased in patients with acute 
thrombosis (Douma et al., 2010; Kabrhel et al. 2010). About 60% of patients < 50 who are 
suspected of having a pulmonary embolus have an abnormal d-dimer result. In contrast, 92% 
of patients > 70 have abnormal d-dimer levels, probably due to comorbid conditions (Douketis 
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et al., 2010). Therefore, if d-dimer test results are negative, deep vein thrombosis or pulmonary 
embolism is unlikely to be present, but positive test results are not useful in patients  
> 70. 
The use of d-dimers as a secondary strategy to exclude the diagnosis of VTE has been 
recommended because the test has a high sensitivity, although a low specificity. False 
positives may occur in patients with recent trauma or surgery, malignancy, pregnancy, 
severe infections, and liver disease.  
12.2.5 Prognosis 
The mortality rate for hospitalized patients > 65 with pulmonary embolism is 21%. If 
pulmonary embolism is the primary diagnosis, the mortality rate is 13%; if it is a secondary 
diagnosis, the rate is 31%. Thus, many diseases and medical conditions--including heart 
failure, chronic obstructive pulmonary disease, cancer, myocardial infarction, stroke, and 
hip fracture--greatly increase the risk of death among hospitalized patients > 65 with 
pulmonary embolism. Prognosis is poorest for patients with severe underlying cardiac or 
pulmonary disease. 
In patients > 65 with a pulmonary embolus, the recurrence rate in the first year is 8%, and 
the 1-year mortality rate is 39% (21% inpatient mortality and an additional 18% mortality 
during the first year). Elderly patients with deep vein thrombosis but without pulmonary 
emboli have a 21% mortality rate in the first year.  
12.2.6 Treatment 
Pulmonary embolectomy is not recommended in the elderly because it has a very low 
success rate and medical therapy is generally quite effective. These procedures should 
regularly be found in the armamentarium of geriatritians.  
Heparin prevents clot formation and extension. As the risk of death from pulmonary 
embolism is the greatest in the first few hours of development of a clot and since diagnostic 
test results often are not available for 8 to 12 hours, heparin should be given to patients with 
a moderate to high clinical probability of pulmonary embolism or deep vein thrombosis 
until all diagnostic results are available. Low-molecular-weight heparin (LMWH) is 
preferred to unfractionated heparin. LMWH can be given subcutaneously once or twice a 
day, and laboratory monitoring may not be necessary. 
Long-term anticoagulation is begun in the hospital with heparin and is continued after 
discharge, usually with warfarin. 
Thrombolytic (fibrinolytic) therapy should be considered for patients with deep vein 
thrombosis involving the iliofemoral system. It is also useful for patients with massive 
pulmonary embolism who have significant pulmonary hypertension, obstruction of 
multiple segments of the pulmonary circulation, right ventricular dysfunction, or systemic 
hypotension. 
12.2.7 Prophylaxis  
Prophylaxis reduces the incidence of fatal pulmonary emboli by two thirds in hospitalized 
patients at risk of developing venous clots. LMWH (eg, enoxaparin 40 mg sc once daily) is 
as effective and safe as prophylaxis with subcutaneous heparin (5000 IU sc bid or tid) and 
may reduce drug-induced adverse effects. Postoperative prophylaxis with LMWH (eg, sc q 
12 h for up to 14 days) also dramatically reduces the incidence of venous thrombosis after 
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knee or hip replacement and in abdominal surgery (Bottaro et al., 2008). For total hip 
replacement, some investigators find that 4 to 6 weeks of LMWH postoperatively may be 
more effective (Kanaan et al., 2007). 
13. Conclusion 
The approach to older patients should be consistently individualised. New diagnostic 
methods and therapeutic algorithms used in acute geriatric wards together enable us to  
treat successfully also multi-morbid patients in advanced age admitted by  
hospital’s doctors. Modern iatrotechniques make possible also the treatment (including 
recovery) and protect self-sufficiency and preserve quality of life in the elderly being  
acutely ill. 
Physicians committed to the care of elderly patients, are challenged with the diagnosis of 
venous thrombembolism due to a higher incidence, co-morbidities masking signs and 
symptoms and burdening  referrals (Siccama et al., 2011).    
We would like to emphasize the need to permanently think of the possibility of PE in elderly 
persons with present risk factors and in suspected cases the use of pretest probability scale 
as Wells or Geneva score as soon as possible (Carrier et al., 2009` Pasha et al., 2010). The 
requirement of correctly assessed diagnosis and starting of therapeutic procedures is crucial 
and essential proceeding for giving the hope to patient and generally, from the professional 
viewpoint, improvement of the prognosis.  
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